Doctor profile · Federal record

Dr. Tirsa Quartullo, CFNP

Family Nurse Practitioner (CMS: Nurse Practitioner) · Phoenix, AZ

  • NPI 1467455477
  • Accepts Medicare
  • MIPS 63.0 / 100 · 2023
  • 24 yrs in practice
  • Female
  • Group practice
  • No sanctions

Practice & contact

NPPES Updated May 11, 2026
Primary practice
3104 E Indian School RD Ste 100
Phoenix, AZ 850166873
(480) 590-6600
fax (480) 590-5695

Credentials & registration

NPPES · NUCC
NPI registered
May 2005 — 21 yrs on file
Profile last updated
July 19, 2024
Year of graduation
2002 — 24 yrs since
Specialty taxonomy
363LF0000X — NUCC code
State license (1)
Arizona #RN118603
Medicaid
AZ #829567

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1467455477. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
14,130
Distinct HCPCS
10
Medicare allowed
$168,023
HCPCS Description Services Patients Avg allowed
J7345 Aminolevulinic acid hcl for topical administration, 10% gel, 10 mg 11,000 53 $2
17003 Destruction of precancer skin growth, 2-14 growths 1,064 157 $6
99213 Established patient office or other outpatient visit, 20-29 minutes 593 343 $74
17000 Destruction of precancer skin growth, 1 growth 344 209 $40
11102 Biopsy of related skin growth, first growth 324 238 $82
11103 Biopsy of related skin growth, each additional growth 242 119 $42
99212 Established patient office or other outpatient visit, 10-19 minutes 150 114 $47
17004 Destruction of precancer skin growth, 15 or more growths 93 79 $137
96574 Application of light with debridement to destroy precancer skin growth 52 50 $231
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg 47 27 $1

In context: peer comparison

Among 230 peers in Phoenix Family Nurse Practitioner, average services per provider: 354. This provider delivers 40× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$2,678
Transactions
134
Manufacturers
15
Payer (manufacturer) Industry Txns Amount
Amgen INC. 11 $552.49
Abbvie INC. 31 $500.02
Dermavant Sciences, INC. 20 $252.43
Galderma Laboratories, L.P. 5 $184.80
Novartis Pharmaceuticals Corporation 9 $183.96
Ucb, INC. 12 $182.23
Sun Pharmaceutical Industries INC. 7 $172.28
Pfizer INC. 9 $151.21
Leo Pharma INC. 9 $136.49
Janssen Biotech, INC. 11 $133.14
Genzyme Corporation 3 $74.68
Arcutis Biotherapeutics, INC. 3 $48.03
E.R. Squibb & Sons, L.L.C. 2 $39.46
Ortho Dermatologics, A Division of Bausch Health US, LLC 1 $22.47
Strata Skin Sciences, INC. 1 $16.94

By nature of payment

Food and Beverage
$2,552
Education
$126

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
474
Patients
167
Total drug cost
$740,772
Drug Type Claims Patients Total cost
Ketoconazole Generic 90 43 $1,660
Clobetasol Propionate Generic 77 36 $3,788
Triamcinolone Acetonide Generic 41 33 $640
Humira(Cf) Pen (Adalimumab) Brand 39 0 $322,788
Betamethasone Dipropionate Generic 36 25 $1,896
Doxycycline Hyclate Generic 33 15 $983
Cosentyx Sensoready (2 Pens) (Secukinumab) Brand 26 0 $231,544
Hydroxyzine Hcl Generic 25 0 $148
Valacyclovir (Valacyclovir Hcl) Brand 18 15 $412
Fluocinonide Generic 17 0 $822

Frequently asked questions

Auto-generated from federal data
What is Dr. Tirsa Quartullo's medical specialty?
Dr. Tirsa Quartullo practices Family Nurse Practitioner in Phoenix, AZ.
Where does Dr. Tirsa Quartullo practice?
Dr. Tirsa Quartullo practices at 3104 E Indian School RD Ste 100, Phoenix, AZ 850166873. Office phone: 4805906600.
What is Dr. Tirsa Quartullo's NPI?
Dr. Tirsa Quartullo's National Provider Identifier (NPI) is 1467455477, issued by NPPES.
Does Dr. Tirsa Quartullo accept Medicare assignment?
Yes. Dr. Tirsa Quartullo accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Tirsa Quartullo commonly perform?
Top Medicare-reported procedures in 2023: Aminolevulinic acid hcl for topical administration, 10% gel, 10 mg (HCPCS J7345); Destruction of precancer skin growth, 2-14 growths (HCPCS 17003); Established patient office or other outpatient visit (HCPCS 99213). Source: CMS Medicare Physician & Other Practitioners file.